:

treatment with single antiplatelet therapy should be
used,
treatment with clopidogrel should be considered as Ô¨Årst
choice in preference to aspirin,
combination therapy with aspirin (75 mg to 100 mg once
daily) plus low dose rivaroxaban (2.5 mg twice daily)
should be considered for people without a high bleeding
risk.
Grade
Best Practice Statement

Certainty of evidence

1124

Journal